Cargando…
Current and future developments in the treatment of virus-induced hypercytokinemia
Emerging pathogenic viruses such as Ebola and Middle Eastern Respiratory Syndrome coronavirus (MERS-CoV) can cause acute infections through the evasion of the host's antiviral immune responses and by inducing the upregulation of inflammatory cytokines. This immune dysregulation, termed a cytoki...
Autores principales: | Wong, Jonathan P, Viswanathan, Satya, Wang, Ming, Sun, Lun-Quan, Clark, Graeme C, D'Elia, Riccardo V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079716/ https://www.ncbi.nlm.nih.gov/pubmed/28128003 http://dx.doi.org/10.4155/fmc-2016-0181 |
Ejemplares similares
-
Continuous hemodiafiltration for hypercytokinemia in tumor lysis syndrome
por: Nakamura, M, et al.
Publicado: (2005) -
Hypercytokinemia and Pathogen–Host Interaction in COVID-19
por: Badawi, Alaa
Publicado: (2020) -
Vascular Leak and Hypercytokinemia Associated with Severe Fever with Thrombocytopenia Syndrome Virus Infection in Mice
por: Westover, Jonna B., et al.
Publicado: (2019) -
Cleavage‐Responsive Biofactory T Cells Suppress Infectious Diseases‐Associated Hypercytokinemia
por: Kim, Hyelim, et al.
Publicado: (2022) -
COVID-19 Severity Correlates with Weaker T-Cell Immunity, Hypercytokinemia, and Lung Epithelium Injury
por: Wang, Zhongfang, et al.
Publicado: (2020)